Nephro Care India (NSE:NEPHROCARE) Total Equity: ₹569.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NEPHROCARE Nephro Care India Ltd NSE:NEPHROCARE
48 GF Score
Price ₹93.25
! 2 Warning Signs
View Full Analysis

What is Nephro Care India Total Equity?

Nephro Care India NSE:NEPHROCARE +2.29% 48 Total Equity is ₹569.0 Mil as of Mar. 2026. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review.

Nephro Care India's total equity for the quarter that ended in Mar. 2026 was ₹569.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nephro Care India Total Equity Historical Data

* Premium members only.

The historical data trend for Nephro Care India's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephro Care India Total Equity Chart

Nephro Care India Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial 4.95 24.38 150.25 534.85 569.03

Nephro Care India Semi-Annual Data
Mar21 Mar22 Mar23 Dec23 Mar24 Sep24 Mar25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 529.46 534.85 554.28 0.00 569.03
NSE:NEPHROCARE
48GF Score
Nephro Care India Ltd NSE:NEPHROCARE
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nephro Care India Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nephro Care India's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=727.209-158.184
=569.0

Nephro Care India's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=727.209-158.184
=569.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹569.0 Mil mean?
Nephro Care India (NSE:NEPHROCARE) has a Total Equity of ₹569.0 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Nephro Care India and its competitors.
Is Nephro Care India's Total Equity too high?
Nephro Care India's current Total Equity is ₹569.0 Mil. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's Total Equity compare to HCA and THC?
Nephro Care India's Total Equity of ₹569.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Nephro Care India and its competitors. Nephro Care India's current Total Equity is ₹569.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current Total Equity of ₹569.0 Mil. The current Total Equity is ₹569.0 Mil. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current Total Equity is ₹569.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nephro Care India Business Description

Address c/o EFC India - Millenium City IT Park, Tower 2, 12th Floor, DN 62, DN Block, Sector V, Bidhannagar, Kolkata, WB, IND, 700091
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score

Get the complete analysis for NSE:NEPHROCARE

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹93.25
Price